Literature DB >> 19506078

Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27.

Melissa C Garcia1, Denise M Ray, Brad Lackford, Mark Rubino, Kenneth Olden, John D Roberts.   

Abstract

Rho GTPases are critical components of cellular signal transduction pathways. Both hyperactivity and overexpression of these proteins have been observed in human cancers and have been implicated as important factors in metastasis. We previously showed that dietary n-6 fatty acids increase cancer cell adhesion to extracellular matrix proteins, such as type IV collagen. Here we report that in MDA-MB-435 human melanoma cells, arachidonic acid activates RhoA, and inhibition of RhoA signaling with either C3 exoenzyme or dominant negative Rho blocked arachidonic acid-induced cell adhesion. Inhibition of the Rho kinase (ROCK) with either small molecule inhibitors or ROCK II-specific small interfering RNA (siRNA) blocked the fatty acid-induced adhesion. However, unlike other systems, inhibition of ROCK did not block the activation of p38 mitogen-activated protein kinase (MAPK); instead, Rho activation depended on p38 MAPK activity and the presence of heat shock protein 27 (HSP27), which is phosphorylated downstream of p38 after arachidonic acid treatment. HSP27 associated with p115RhoGEF in fatty acid-treated cells, and this association was blocked when p38 was inhibited. Furthermore, siRNA knockdown of HSP27 blocked the fatty acid-stimulated Rho activity. Expression of dominant negative p115-RhoGEF or p115RhoGEF-specific siRNA inhibited both RhoA activation and adhesion on type IV collagen, whereas a constitutively active p115RhoGEF restored the arachidonic acid stimulation in cells in which the p38 MAPK had been inhibited. These data suggest that n-6 dietary fatty acids stimulate a set of interactions that regulates cell adhesion through RhoA and ROCK II via a p38 MAPK-dependent association of HSP27 and p115RhoGEF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506078      PMCID: PMC2742859          DOI: 10.1074/jbc.M109.020271

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

Review 1.  Current knowledge of the large RhoGAP family of proteins.

Authors:  Joseph Tcherkezian; Nathalie Lamarche-Vane
Journal:  Biol Cell       Date:  2007-02       Impact factor: 4.458

Review 2.  Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.

Authors:  Celine Didelot; David Lanneau; Mathilde Brunet; Anne-Laure Joly; Aurelie De Thonel; Gabriela Chiosis; Carmen Garrido
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

3.  A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin.

Authors:  Adi D Dubash; Krister Wennerberg; Rafael García-Mata; Marisa M Menold; William T Arthur; Keith Burridge
Journal:  J Cell Sci       Date:  2007-10-30       Impact factor: 5.285

4.  MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27.

Authors:  Chunlei Zheng; Ziyang Lin; Zhizhuang Joe Zhao; Yajun Yang; Hanben Niu; Xun Shen
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

5.  MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research.

Authors:  James M Rae; Chad J Creighton; Jeanne M Meck; Bassem R Haddad; Michael D Johnson
Journal:  Breast Cancer Res Treat       Date:  2006-09-27       Impact factor: 4.872

6.  p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho.

Authors:  Gregg A Wildenberg; Michael R Dohn; Robert H Carnahan; Michael A Davis; Nichole A Lobdell; Jeffrey Settleman; Albert B Reynolds
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

7.  HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression.

Authors:  Joong-Won Lee; Hee-Jin Kwak; Je-Jung Lee; Yong-Nyun Kim; Jung Weon Lee; Myung-Jin Park; Seung Eun Jung; Seok-Il Hong; Jeong-Hwa Lee; Jae-Seon Lee
Journal:  Eur J Cell Biol       Date:  2008-05-09       Impact factor: 4.492

8.  Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex.

Authors:  Rui Wu; Hina Kausar; Paul Johnson; Diego E Montoya-Durango; Michael Merchant; Madhavi J Rane
Journal:  J Biol Chem       Date:  2007-05-17       Impact factor: 5.157

9.  Cytochrome p450 epoxygenase promotes human cancer metastasis.

Authors:  Jian-Gang Jiang; Yao-Gui Ning; Chen Chen; Ding Ma; Zhen-Jun Liu; Shilin Yang; Jianfeng Zhou; Xiao Xiao; Xin A Zhang; Matthew L Edin; Jeffrey W Card; Jianing Wang; Darryl C Zeldin; Dao Wen Wang
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling.

Authors:  Kate A Alford; Sarah Glennie; Bryony R Turrell; Lesley Rawlinson; Jeremy Saklatvala; Jonathan L E Dean
Journal:  J Biol Chem       Date:  2007-01-03       Impact factor: 5.157

View more
  26 in total

Review 1.  Viral activation of stress-regulated Rho-GTPase signaling pathway disrupts sites of mRNA degradation to influence cellular gene expression.

Authors:  Jennifer A Corcoran; Craig McCormick
Journal:  Small GTPases       Date:  2015-10-19

2.  Long-chain Acyl-CoA synthetase 4A regulates Smad activity and dorsoventral patterning in the zebrafish embryo.

Authors:  Rosa Linda Miyares; Cornelia Stein; Björn Renisch; Jennifer Lynn Anderson; Matthias Hammerschmidt; Steven Arthur Farber
Journal:  Dev Cell       Date:  2013-12-12       Impact factor: 12.270

3.  Arachidonic acid stimulates formation of a novel complex containing nucleolin and RhoA.

Authors:  Melissa C Garcia; Jason Williams; Katina Johnson; Kenneth Olden; John D Roberts
Journal:  FEBS Lett       Date:  2011-02-01       Impact factor: 4.124

4.  Engineered biological nanofactories trigger quorum sensing response in targeted bacteria.

Authors:  Rohan Fernandes; Varnika Roy; Hsuan-Chen Wu; William E Bentley
Journal:  Nat Nanotechnol       Date:  2010-01-17       Impact factor: 39.213

5.  Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.

Authors:  Anna A Birukova; Yufeng Tian; Angelo Meliton; Alan Leff; Tinghuai Wu; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-17       Impact factor: 5.464

6.  The role of Rho/Rho-kinase pathway in the expression of ICAM-1 by linoleic acid in human aortic endothelial cells.

Authors:  Chang Hee Jung; Woo Je Lee; Jenie Yoonoo Hwang; So Mi Seol; Yun Mi Kim; Yoo La Lee; Ji Hyun Ahn; Joong-Yeol Park
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

7.  Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.

Authors:  Hai-Bo Tan; Yi-Sheng Zhong; Yu Cheng; Xi Shen
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

8.  Role of RhoA and its effectors ROCK and mDia1 in the modulation of deformation-induced FAK, ERK, p38, and MLC motogenic signals in human Caco-2 intestinal epithelial cells.

Authors:  Lakshmi S Chaturvedi; Harold M Marsh; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-17       Impact factor: 4.249

9.  p38 mitogen-activated protein kinase interacts with vinculin at focal adhesions during fatty acid-stimulated cell adhesion.

Authors:  Margaret D George; Robert N Wine; Brad Lackford; Grace E Kissling; Steven K Akiyama; Kenneth Olden; John D Roberts
Journal:  Biochem Cell Biol       Date:  2013-06-24       Impact factor: 3.626

Review 10.  Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; Jun-Tzu Chao; Du-Shieng Chien; Yi-Wen Chu
Journal:  Pharmacol Ther       Date:  2016-01-22       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.